InvestorsHub Logo
Followers 12
Posts 764
Boards Moderated 0
Alias Born 06/19/2013

Re: EYEBUYSTOX post# 186324

Thursday, 08/14/2014 5:40:21 AM

Thursday, August 14, 2014 5:40:21 AM

Post# of 346214
I too think that it is a possibility, but quite far from certain as most of the things on dia's list. I've listed some reasons on why I think a Bayer partnership could make sense, in post 186353. But that is only providing bavituximab + sorafenib Phase II data is worthy, otherwise we wouldn't get Bayer's attention.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News